Covid catalyses investment in biotech with 2022 set to be 'breakout' year

Tremendous potential, particularly in the spatial biology sector

clock • 4 min read
The pandemic has acted as a catalyst for biotech and health industries
Image:

The pandemic has acted as a catalyst for biotech and health industries

The pandemic has acted as a catalyst for the biotechnology and health industries, accelerating the pace at which new technologies are being adopted.

Following the mass rollout of mRNA vaccines worldwide, some analysts argue that 2022 could be a "breakout" year for the industry, particularly in the spatial biology sector. Gareth Blades, analyst at...

To continue reading this article...

Join Investment week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Equities

The Twitter shareholders said Musk purchased Twitter stock at an artificially low price.
US

Twitter investors sue Elon Musk for stock 'manipulation' during takeover bid

Accused of delaying stake disclosure

clock 27 May 2022 • 1 min read
Dale Nicholls, portfolio manager of the Fidelity China Special Situations trust

Fidelity's Nicholls bets on Alibaba and ByteDance

Predicts short-term slowdown

Elliot Gulliver-Needham
clock 26 May 2022 • 3 min read
John Redwood, chief global strategist for Charles Stanley

Charles Stanley's Redwood: Chimerica is so last decade

Both have hit problems in 2022

John Redwood
clock 25 May 2022 • 6 min read
Trustpilot